Megan E Pace Insider Trading $VRTX VERTEX PHARMACEUTICALS INC / MA
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Megan E Pace.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Megan E Pace. Megan E Pace is SVP, Corp. Communications in VERTEX PHARMACEUTICALS INC / MA ($VRTX).
Megan E Pace in VERTEX PHARMACEUTICALS INC / MA
Trading Symbol: VRTXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Megan E Pace: SVP, Corp. Communications
Holdings: 43,350 shares
Current Value: $3,764,514
Latest Transaction: Nov 19 2014
$VRTX Market Capitalization: $21.78B
$VRTX Previous Close: $86.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Megan E Pace in VERTEX PHARMACEUTICALS INC / MA
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 19 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Sell | S | 111.93 | 33 | 3,694 | 43,350 | 43.4 K to 43.4 K (-0.08 %) |
Nov 03 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Grant | A | 0.01 | 20,000 | 200 | 43,350 | 23.4 K to 43.4 K (+85.65 %) |
Oct 01 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Option Exercise | M | 77.31 | 6,875 | 531,506 | 48,125 | |
Oct 01 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Option Exercise | M | 83.36 | 6,875 | 573,100 | 20,625 | |
Oct 01 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Option Exercise | M | 45.11 | 17,157 | 773,952 | 28,593 | |
Oct 01 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Option Exercise | M | 48.74 | 15,250 | 743,285 | 15,250 | |
Oct 01 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Option Exercise | M | 37.86 | 3,532 | 133,722 | 4,218 | |
Oct 01 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Option Exercise | M | 51.75 | 5,625 | 291,094 | 1,875 | |
Oct 01 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Option Exercise | M | 38.80 | 1,172 | 45,474 | 2,344 | |
Oct 01 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Sell | S | 113.90 | 11,629 | 1,324,543 | 23,350 | 35 K to 23.4 K (-33.25 %) |
Oct 01 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Sell | S | 113.08 | 15,400 | 1,741,432 | 34,979 | 50.4 K to 35 K (-30.57 %) |
Oct 01 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Sell | S | 112.21 | 21,881 | 2,455,267 | 50,379 | 72.3 K to 50.4 K (-30.28 %) |
Oct 01 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Sell | S | 111.32 | 7,576 | 843,360 | 72,260 | 79.8 K to 72.3 K (-9.49 %) |
Oct 01 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Buy | M | 77.31 | 6,875 | 531,506 | 79,836 | 73 K to 79.8 K (+9.42 %) |
Oct 01 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Buy | M | 83.36 | 6,875 | 573,100 | 72,961 | 66.1 K to 73 K (+10.40 %) |
Oct 01 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Buy | M | 45.11 | 17,157 | 773,952 | 66,086 | 48.9 K to 66.1 K (+35.07 %) |
Oct 01 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Buy | M | 48.74 | 15,250 | 743,285 | 48,929 | 33.7 K to 48.9 K (+45.28 %) |
Oct 01 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Buy | M | 37.86 | 3,532 | 133,722 | 33,679 | 30.1 K to 33.7 K (+11.72 %) |
Oct 01 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Buy | M | 51.75 | 5,625 | 291,094 | 30,147 | 24.5 K to 30.1 K (+22.94 %) |
Oct 01 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Buy | M | 38.80 | 1,172 | 45,474 | 24,522 | 23.4 K to 24.5 K (+5.02 %) |
Jul 17 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Option Exercise | A | 96.87 | 27,500 | 2,663,925 | 27,500 | |
Jun 26 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Option Exercise | M | 38.80 | 5,234 | 203,079 | 3,516 | |
Jun 26 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Option Exercise | M | 37.29 | 7,500 | 279,675 | 0 | |
Jun 26 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Sell | S | 98.03 | 12,734 | 1,248,314 | 23,350 | 36.1 K to 23.4 K (-35.29 %) |
Jun 26 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Buy | M | 38.80 | 5,234 | 203,079 | 36,084 | 30.9 K to 36.1 K (+16.97 %) |
Jun 26 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Buy | M | 37.29 | 7,500 | 279,675 | 30,850 | 23.4 K to 30.9 K (+32.12 %) |
May 19 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Sell | S | 67.00 | 22 | 1,474 | 23,350 | 23.4 K to 23.4 K (-0.09 %) |
May 19 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Sell | S | 65.57 | 347 | 22,753 | 23,372 | 23.7 K to 23.4 K (-1.46 %) |
May 06 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Sell | S | 69.42 | 100 | 6,942 | 23,350 | 23.5 K to 23.4 K (-0.43 %) |
May 06 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Sell | S | 67.94 | 400 | 27,176 | 23,450 | 23.9 K to 23.5 K (-1.68 %) |
May 06 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Sell | S | 67.01 | 500 | 33,505 | 23,850 | 24.4 K to 23.9 K (-2.05 %) |
Feb 07 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Option Exercise | A | 77.31 | 55,000 | 4,252,050 | 55,000 | |
Feb 07 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Grant | A | 0.01 | 14,250 | 143 | 24,350 | 10.1 K to 24.4 K (+141.09 %) |
Jan 23 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Sell | S | 85.00 | 1,250 | 106,250 | 10,100 | 11.4 K to 10.1 K (-11.01 %) |
Jan 08 2014 | VRTX | VERTEX PHARMACEUTI ... | Pace Megan E | SVP, Corp. Communic ... | Sell | S | 75.00 | 838 | 62,850 | 11,350 | 12.2 K to 11.4 K (-6.88 %) |
Page: 1